Amdocs Limited (NASDAQ:DOX – Get Free Report) shares reached a new 52-week low on Tuesday following a weaker than expected earnings announcement. The stock traded as low as $74.25 and last traded at $73.3010, with a volume of 2350850 shares traded. The stock had previously closed at $81.01.
The technology company reported $1.63 EPS for the quarter, missing the consensus estimate of $1.75 by ($0.12). Amdocs had a net margin of 12.46% and a return on equity of 19.78%.
Amdocs Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st were given a dividend of $0.527 per share. The ex-dividend date was Wednesday, December 31st. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.8%. Amdocs’s dividend payout ratio (DPR) is currently 41.78%.
Analyst Upgrades and Downgrades
Read Our Latest Analysis on DOX
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Pzena Investment Management LLC grew its stake in Amdocs by 0.6% during the 3rd quarter. Pzena Investment Management LLC now owns 6,593,249 shares of the technology company’s stock worth $540,976,000 after purchasing an additional 42,184 shares in the last quarter. LSV Asset Management boosted its stake in shares of Amdocs by 7.6% in the 3rd quarter. LSV Asset Management now owns 3,648,703 shares of the technology company’s stock valued at $299,376,000 after buying an additional 257,193 shares during the period. Allspring Global Investments Holdings LLC grew its position in shares of Amdocs by 1.8% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock worth $253,786,000 after buying an additional 54,676 shares in the last quarter. Wellington Management Group LLP increased its stake in shares of Amdocs by 3.0% during the third quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company’s stock worth $258,583,000 after buying an additional 91,900 shares during the period. Finally, Vanguard Group Inc. increased its stake in shares of Amdocs by 0.3% during the third quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock worth $251,602,000 after buying an additional 9,207 shares during the period. 92.02% of the stock is currently owned by hedge funds and other institutional investors.
Amdocs Trading Down 8.6%
The company’s fifty day moving average is $80.42 and its two-hundred day moving average is $82.74. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.23. The stock has a market cap of $7.99 billion, a price-to-earnings ratio of 14.66, a PEG ratio of 1.39 and a beta of 0.40.
About Amdocs
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Featured Articles
- Five stocks we like better than Amdocs
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Trump Planning to Use Public Law 63-43: Prepare Now
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
